London, July 25, 2013: The International Tennis Federation announced today that Viktor Troicki has been found to have committed an Anti-Doping Rule Violation under Article 2.3 of the Tennis Anti-Doping Programme (refusing or failing without compelling justification to submit to sample collection).
Mr Troicki, a 27-year-old player from Serbia, was notified on 15 April 2013 that he had been selected to provide a urine sample and a blood sample in association with his participation at the Rolex Monte Carlo Masters event.
Mr Troicki provided a urine sample, but did not provide a blood sample. He asserted to an independent tribunal that he was assured by the Doping Control Officer (DCO) that it would be acceptable not to provide a sample on account of him feeling unwell that day. However, the tribunal concluded that the DCO told Mr Troicki that she could not advise him as to whether his reason for not providing a blood sample was valid, and that no such assurances were given by her.
Accordingly, the tribunal determined that Mr Troicki’s actions constituted a failure and a refusal to provide a blood sample, and that his explanation for not doing so did not constitute compelling justification under Article 2.3. However, the tribunal accepted that the stress that Mr Troicki was under at the time entitled him to mitigation under Article 10.5.2.
Mr Troicki’s commission of an Anti-Doping Rule Violation under Article 2.3 of the Programme was, therefore, confirmed, and the tribunal determined that he is suspended from participation for a period of 18 months, and so ending at midnight on 24 January 2015. It was also determined that Mr Troicki’s results at the 2013 Monte Carlo Rolex Masters event should be disqualified, with resulting forfeiture of the ranking points and prize money that he won at that event.
The Tennis Anti-Doping Programme is a comprehensive and internationally recognised drug-testing programme that applies to all players competing at Grand Slam tournaments and events sanctioned by the ITF, ATP, and WTA. Players are tested for substances prohibited by the World Anti-Doping Agency and, upon a finding that an Anti-Doping Rule Violation has been committed, sanctions are imposed in accordance with the requirements of the Tennis Anti-Doping Programme and World Anti-Doping Code. More background information on the Programme, sanctions, tennis statistics and related information can be found at www.itftennis.com/antidoping